With a market cap of $11.4 billion, Healthpeak Properties, Inc. (DOC) owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery across the United States. The company manages a diversified portfolio spanning outpatient medical, lab, and continuing care retirement community properties.
The Denver, Colorado-based company is expected to release its fiscal Q1 2026 results soon. Ahead of this event, analysts project DOC to report an FFO as Adjusted of $0.44 per share, a decline of 4.4% from $0.46 in the year-ago quarter. It has surpassed or met Wall Street's bottom-line estimates in the last four quarterly reports.
For fiscal 2026, analysts forecast Healthpeak Properties to report FFO as Adjusted of $1.73 per share, down nearly 6% from $1.84 in fiscal 2025. However, FFO as Adjusted is anticipated to grow 2.9% year-over-year to $1.78 per share in fiscal 2027.
DOC stock has decreased nearly 17% over the past 52 weeks, lagging behind the broader S&P 500 Index's ($SPX) nearly 17% gain and the State Street Real Estate Select Sector SPDR ETF's (XLRE) 2% dip over the same time frame.
Shares of Healthpeak Properties fell 2.8% following its Q4 2025 results on Feb. 2, primarily due to weak forward guidance, with 2026 Nareit FFO projected at $1.70 per share - $1.74 per share, below its 2025 level of $1.81. Additionally, a drop in AFFO to $0.40 from $0.44 year-over-year and heavy capital recycling plans, including ~$1 billion in asset sales and uncertainty around the Janus Living IPO, added to concerns.
Analysts' consensus view on DOC stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 18 analysts covering the stock, seven suggest a "Strong Buy," two give a "Moderate Buy," and nine recommend a "Hold." The average analyst price target for Healthpeak Properties is $19.47, indicating a potential upside of 18.5% from the current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
